Odyssean »

Royalty Pharma shares owned by Odyssean

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.0M 54k 56.07

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
BlackRock
FMR
Swedbank AB
State Street Corporation
Baillie Gifford & Co
Capital World Investors
Geode Capital Management
Adage Capital Partners GP
Caledonia
Vanguard Capital Management
Northern Trust
Royal London Asset Management
Legal & General Group

View all funds holding Royalty Pharma